Carbohydrate antigen 15.3 as a serum biomarker of interstitial lung disease in systemic sclerosis patients

Ca 15.3 is a rapid and inexpensive candidate biomarker for SSc-ILD being proportional to the extent of lung injury and specific and sensitive in assessing meaningful extents of the disease with prognostic significance.